What volume of 5% albumin should be used as replacement fluid during therapeutic plasma exchange for a 70‑kg adult lung‑transplant recipient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Albumin Dosing for Therapeutic Plasma Exchange in Lung Transplant Recipients

For a 70-kg adult lung transplant recipient undergoing therapeutic plasma exchange, use approximately 2,800-4,200 mL of 5% albumin solution, calculated as 1-1.5 plasma volumes (40-60 mL/kg body weight).

Volume Calculation

The standard replacement volume for therapeutic plasma exchange is 1-1.5 plasma volumes, which translates to:

  • 40-60 mL/kg of body weight 1
  • For a 70-kg patient: 2,800-4,200 mL total volume
  • This is typically administered as 4-5% albumin solution 2, 3

Rationale for Albumin as Primary Replacement Fluid

5% albumin in saline is the recommended replacement solution for most therapeutic plasma exchange procedures 2, 3. The key advantages include:

  • Viral safety: Pasteurized for viral inactivation 2, 3
  • Low reaction risk: Very unlikely to cause febrile or allergic reactions 2, 3
  • Convenience: Easy to store and administer without need for thawing or blood type matching 2, 3
  • Adequate volume expansion: Provides effective intravascular volume support 4

Special Considerations for Lung Transplant Recipients

In the lung transplant population specifically, albumin use during the perioperative period has been studied:

  • Point-of-care guided albumin administration combined with targeted coagulopathy management improved early allograft function (Horowitz index 402.87 vs 308.03, p<0.001) and reduced PGD grade 2-3 at 72 hours (3.2% vs 25%, p=0.003) 5
  • Albumin helps maintain intravascular volume while minimizing total fluid administration, which is critical since excessive fluid is associated with higher PGD rates 6

Practical Administration Protocol

Standard approach for TPE in this patient:

  1. Calculate total exchange volume: 70 kg × 40-60 mL/kg = 2,800-4,200 mL
  2. Use 4-5% albumin solution as primary replacement fluid
  3. Typical regimen: 8 treatments with exchange volume of 1-1.5 plasma volumes 1
  4. Consider continuous albumin infusion throughout the session rather than bolus at the end to maintain more stable relative blood volume and prevent hypotensive episodes 7

When to Consider Fresh Frozen Plasma Instead

Reserve FFP for specific situations 2, 3:

  • Pre-existing coagulopathy requiring clotting factor replacement
  • Thrombotic thrombocytopenic purpura (TTP)
  • Active bleeding requiring comprehensive plasma protein replacement

For routine TPE in a lung transplant recipient without coagulopathy, albumin alone is appropriate and preferred 2, 3.

Electrolyte Monitoring

A critical caveat: Standard 5% albumin solutions have non-physiologic electrolyte concentrations, particularly low calcium 8. Monitor and supplement:

  • Calcium levels (risk of hypocalcemia during exchange)
  • Sodium, potassium, chloride as needed
  • Consider using albumin preparations with adjusted electrolyte concentrations if available 8

Related Questions

What is the recommended dose of 5% albumin for replacement during a plasma‑volume exchange plasmapheresis in an average adult (≈70 kg, plasma volume ≈3 L)?
What replacement solution is used during plasmapheresis?
How to reconstitute albumin 5% for volume expansion?
Can fresh frozen plasma (FFP) be used as a substitute for albumin to replace serum albumin?
Why is fresh‑frozen plasma preferred over 5 % albumin for therapeutic plasma exchange in patients with coagulopathy, bleeding, anticoagulation, or severe hypogammaglobulinemia?
In a patient taking amiodarone who has a TSH level of 7.18 mIU/L, what does this indicate and how should it be managed?
What is the recommended dosing and duration of amoxicillin and levofloxacin (with a proton‑pump inhibitor) for treating Helicobacter pylori infection, and what contraindications or alternative regimens should be considered?
In a 68-year-old woman with type 2 diabetes mellitus, hypertension, and end-stage renal disease on hemodialysis presenting with dyspnea, elevated jugular venous pressure, and bilateral lower extremity edema, which ECG finding is most likely?
What is the therapeutic plasma exchange protocol for a 70‑kg lung transplant recipient?
What is the recommended duration of alendronate therapy for osteoporosis and the criteria for initiating a drug holiday?
What are the recommended dosing guidelines, renal and hepatic dose adjustments, cardiac monitoring requirements, common adverse effects, and alternative therapies for lacosamide in adults with focal seizures?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.